Mechanisms of ErbB2-mediated paclitaxel resistance and trastuzumab-mediated paclitaxel sensitization in ErbB2-overexpressing breast cancers.
about
Gene expression profiling reveals epithelial mesenchymal transition (EMT) genes can selectively differentiate eribulin sensitive breast cancer cellsDetermination of key aspects of precursor cell proliferation, cell cycle length and kinetics in the adult mouse subgranular zone.Signaling Pathway of GP88 (Progranulin) in Breast Cancer Cells: Upregulation and Phosphorylation of c-myc by GP88/Progranulin in Her2-Overexpressing Breast Cancer CellsPrediction of paclitaxel sensitivity by CDK1 and CDK2 activity in human breast cancer cellsIdentification of selective cytotoxic and synthetic lethal drug responses in triple negative breast cancer cells.HER2 overexpression as a prognostic factor in metastatic breast cancer patients treated with high-dose chemotherapy and autologous stem cell support.
P2860
Mechanisms of ErbB2-mediated paclitaxel resistance and trastuzumab-mediated paclitaxel sensitization in ErbB2-overexpressing breast cancers.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Mechanisms of ErbB2-mediated p ...... overexpressing breast cancers.
@ast
Mechanisms of ErbB2-mediated p ...... overexpressing breast cancers.
@en
Mechanisms of ErbB2-mediated p ...... overexpressing breast cancers.
@nl
type
label
Mechanisms of ErbB2-mediated p ...... overexpressing breast cancers.
@ast
Mechanisms of ErbB2-mediated p ...... overexpressing breast cancers.
@en
Mechanisms of ErbB2-mediated p ...... overexpressing breast cancers.
@nl
prefLabel
Mechanisms of ErbB2-mediated p ...... overexpressing breast cancers.
@ast
Mechanisms of ErbB2-mediated p ...... overexpressing breast cancers.
@en
Mechanisms of ErbB2-mediated p ...... overexpressing breast cancers.
@nl
P1433
P1476
Mechanisms of ErbB2-mediated p ...... overexpressing breast cancers.
@en
P356
10.1016/S0093-7754(01)90277-5
P433
5 Suppl 16
P577
2001-10-01T00:00:00Z